What does Eluxadoline (Viberzi) do in plain English—and how does it work inside your body?
Eluxadoline is an FDA-regulated mu-Opioid Receptor Agonist (RxNorm RxCUI RXN-61874100-2951). Mechanistically, Biochemical activity of Eluxadoline reflects mu-opioid receptor agonist pathway engagement after oral-route dosing (100 mg/1 Tablet, Film Coated and 75 mg/1 Tablet, Film Coated, manufactured/labeled by Allergan, Inc., NDC 61874-100, 61874-075), supporting titratable maintenance pharmacotherapy. [1][2].
When your doctor writes a prescription for Eluxadoline (RxNorm RxCUI RXN-61874100-2951, also dispensed under brand names including Viberzi), the goal is to target the root physiological pathway driving your condition rather than just masking surface symptoms [1]. According to the official FDA DailyMed package insert, Biochemical activity of Eluxadoline reflects mu-opioid receptor agonist pathway engagement after oral-route dosing (100 mg/1 Tablet, Film Coated and 75 mg/1 Tablet, Film Coated, manufactured/labeled by Allergan, Inc., NDC 61874-100, 61874-075), supporting titratable maintenance pharmacotherapy. [2].
Across real-world patient logs on dotMD (88% positive worth-it rating), patients do best when they understand both what the medication is doing on day 1 and how long it takes to reach steady-state protection [3].
Check the imprint code on your Eluxadoline tablet bottle and confirm with your pharmacist that it matches your prescribed strength (100 mg/1 Tablet, Film Coated, 75 mg/1 Tablet, Film Coated).